相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhibiting MAPK pathway
Wen Li et al.
GENE (2021)
Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways
Qiang Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
Li Liu et al.
BIOLOGICAL RESEARCH (2019)
Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of non-small cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax signaling pathways
Jie Li et al.
ONCOLOGY LETTERS (2018)
Randomized, Open-Label Phase II Study Comparing Capecitabine-Cisplatin Every 3 Weeks with S-1-Cisplatin Every 5 Weeks in Chemotherapy-Naive Patients with HER2-Negative Advanced Gastric Cancer: OGSG1105, HERBIS-4A Trial
Hisato Kawakami et al.
ONCOLOGIST (2018)
Anti-tumor and chemosensitization effects of Cryptotanshinone extracted from Salvia miltiorrhiza Bge. on ovarian cancer cells in vitro
Guoqiang Jiang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2017)
Anti-angiogenesis target therapy for advanced osteosarcoma
Lu Xie et al.
ONCOLOGY REPORTS (2017)
Berberine Enhances Chemosensitivity and Induces Apoptosis Through Dose-orchestrated AMPK Signaling in Breast Cancer
Yue Pan et al.
JOURNAL OF CANCER (2017)
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
Jinwan Wang et al.
GASTRIC CANCER (2016)
Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation
Jose Alexandre Ferreira et al.
DRUG RESISTANCE UPDATES (2016)
Metastatic osteosarcoma: a challenging multidisciplinary treatment
Cristina Meazza et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis
Yuwan Zhao et al.
ONCOLOGY REPORTS (2016)
Bioactive natural products in cancer prevention and therapy: Progress and promise
Anupam Bishayee et al.
SEMINARS IN CANCER BIOLOGY (2016)
Oncogenic KRAS signaling and YAP1/β-catenin: Similar cell cycle control in tumor initiation
Ruth Nussinov et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Berberine Exhibits Antitumor Effects in Human Ovarian Cancer Cells
Ping Jin et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2015)
Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer
Parham Jabbarzadeh Kaboli et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Berberine induces apoptosis and DNA damage in MG-63 human osteosarcoma cells
Yu Zhu et al.
MOLECULAR MEDICINE REPORTS (2014)
Berberine and its derivatives: a patent review (2009-2012)
Inder Pal Singh et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling
Junfang Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Bone Cancer Clinical Practice Guidelines in Oncology
J. Sybil Biermann et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2013)
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the natural plant product berberine
William H. Chappell et al.
CELL CYCLE (2012)
Agents that act luminally to treat diarrhoea and constipation
Stacy Menees et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Gli Proteins in Development and Disease
Chi-chung Hui et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Dietary Administration of Berberine or Phellodendron amurense Extract Inhibits Cell Cycle Progression and Lung Tumorigenesis
Michael A. James et al.
MOLECULAR CARCINOGENESIS (2011)
Emerging drugs for high-grade osteosarcoma
Claudia Maria Hattinger et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
Strategies for the targeted delivery of therapeutics for osteosarcoma
Dennis P. M. Hughes
EXPERT OPINION ON DRUG DELIVERY (2009)
Uterine cervical carcinoma: Role of matrix metalloproteinases (Review)
Massimo Libra et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
p53 Cooperates Berberine-Induced Growth Inhibition and Apoptosis of Non-Small Cell Human Lung Cancer Cells In Vitro and Tumor Xenograft Growth In Vivo
Santosh K. Katiyar et al.
MOLECULAR CARCINOGENESIS (2009)
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin. receptor expression
Wei-Jia Kong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Berberine, a natural product, combined with cisplatin enhanced apoptosis through a mitochondria/caspase-mediated pathway in HeLa cells
Myung-Ja Youn et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Primary bone osteosarcoma in the pediatric age: State of the art
Alessandra Longhi et al.
CANCER TREATMENT REVIEWS (2006)
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S. Fulda et al.
ONCOGENE (2006)
Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells
SK Mantena et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifolium.: Structural aspects
L Racková et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Synergy in a medicinal plant:: Antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor
FR Stermitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)